Additionally, understanding the bioavailability, metabolic stability, and optimal dosing strategies for BRP will be crucial for its therapeutic success
Subsequently, Moore proposed the hypothesis that intestinal secretions might have a glycemic-lowering effect in diabetics, which was the first study to suggest an effect of intestinal secretions on blood glucose ( The 21st century has seen significant progress in GLP-1R agonist research, with liraglutide (exenatide) becoming the first GLP-1R agonist to be approved by the US Food and Drug Administration (FDA) for the treatment of T2DM in 2005 ( ) and dulaglutide (Trulicity ) have been approve ( ), with 94% homology to human GLP-1, were approved in 2019 as the first GLP-1R agonists for oral administration (Table 2)
L.HarperJ
Additionally, they are all broken down similarly by dipeptidyl peptidase-4 (DPP-4) though GIP breakdown occurs at a slower rate than GLP-1 breakdown [16]
If you're discontinuing Lexapro or Prozac and have questions and concerns about your metabolism, weight, appetite, or any other medication side effects or results, see what your doctor recommends